CMS Strayed From Its Lane With Alzheimer’s Drugs Decision, US Congressional Republicans Say

Recent congressional reactions to the Medicare national coverage determination offers insight into policies around CMS decision-making that could advance if Republicans gain more control in Congress in 2023.